US › Healthcare

Elutia Inc. (ELUT)

US · Healthcare · Medical Devices

$0.87+0.59%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$3.1M
Revenue YoY
-48.4%
Net profit
$-7.5M
Profit YoY
-89.9%
EPS
$-0.17
EPS estimate
$-0.15
Net margin
-239.9%

EPS came in at -0.17 against a street estimate of -0.15 — a miss of 13.3%.

Key statistics

Market cap
$37.9M
Forward P/E
0.0
P/B
1.71
Book value
$0.51
EPS (TTM)
$-0.66
52-week high
$2.50
52-week low
$0.50
50-day MA
$0.99
200-day MA
$0.94
Beta
0.85

Analyst view

Analysts rate Elutia Inc. a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $5.00.

Shareholding

Insiders
3.51%
Institutions
45.56%

Largest institutional holders

FundStake
AIGH Capital Management, LLC8.13%
Nantahala Capital Management, LLC7.20%
Knollwood Investment Advisory LLC5.78%
SILVERARC CAPITAL MANAGEMENT, LLC5.65%
Vanguard Capital Management, LLC2.32%
Perkins Capital Management Inc1.71%
Geode Capital Management, LLC0.66%
CI Private Wealth LLC0.56%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Elutia Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.